18F-FDG PET/CT for Staging and Restaging of Breast Cancer - Archive ouverte HAL
Article Dans Une Revue Journal of Nuclear Medicine Année : 2016

18F-FDG PET/CT for Staging and Restaging of Breast Cancer

Résumé

Many studies have pointed out the role of (18)F-FDG PET/CT (or (18)F-FDG PET) in patients with clinical stage III or II breast cancer. (18)F-FDG PET/CT might advantageously replace other staging procedures, such as bone scanning and possibly contrast-enhanced CT of the thorax or abdomen-pelvis. We discuss the findings, locoregional or distant, that can be expected in different categories of breast cancer and their impact on prognosis and management. We also discuss the role of (18)F-FDG PET/CT in restaging and how (18)F-FDG PET/CT compares with conventional techniques in restaging for patients with suspected disease recurrence. We conclude with some recommendations for clinical practice and future research.

Dates et versions

hal-03121854 , version 1 (26-01-2021)

Identifiants

Citer

David Groheux, Alexandre Cochet, Olivier Humbert, Jean-Louis Alberini, Elif Hindié, et al.. 18F-FDG PET/CT for Staging and Restaging of Breast Cancer. Journal of Nuclear Medicine, 2016, 57 (Supplement_1), pp.17S-26S. ⟨10.2967/jnumed.115.157859⟩. ⟨hal-03121854⟩

Collections

FNCLCC CGFL
27 Consultations
0 Téléchargements

Altmetric

Partager

More